ArticleTranslational lung cancer research2024

The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity.

Dariusz M Kowalski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.